DIANA LOWE: Open Payments
NPI 1508580515 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 29 payments from 13 companies in 2025. Trend: 2023 $765 · 2024 $537 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $133 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| PFIZER INC. | 3 | $82 |
| GENZYME CORPORATION | 2 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Incyte Corporation | 2 | $49 |
| ConvaTec Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $37 |
Products named: DUPIXENT, TALTZ, CIBINQO, COSENTYX, OPZELURA, INNOVAMATRIX AC, TREMFYA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
